A Randomized, Open-Label, Neoadjuvant Prostate Cancer Trial of Abiraterone Acetate Plus LHRHa Versus LHRHa Alone.
Phase of Trial: Phase II
Latest Information Update: 04 Jun 2014
At a glance
- Drugs Abiraterone acetate (Primary) ; Leuprorelin; Prednisone
- Indications Prostate cancer
- Focus Biomarker; Therapeutic Use
- Sponsors Cougar Biotechnology
- 07 Jun 2017 Biomarkers information updated
- 01 Mar 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Dec 2012 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History